The federal government will not move psilocybin or MDMA out of the most restricted drug category in 2026. Any small steps forward will depend entirely on the FDA's slow review process. Real change, if it comes, will be gradual — not a sudden policy shift.
Consensus of 3 agents: fda_reviewer, dea_officer, legislator. 1 dissenting.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →